DISTINCT CSF-COMPARTMENTALIZED ANTIBODY FUCTIONALITIES DURING HSV1 INFECTION ASSOCIATE WITH SITE OF INFECTION, DISEASE SEVERITY AND PREDICT POST-HERPES AUTOIMMUNE ENCEPHALITIS
Institut d'Investigacions Biomédiques August Pi i Sunyer (IDIBAPS)
Presentation
Date TBA
Event Information
Poster Board
PS04-08PM-005
Poster
View posterAbstract
We deeply characterized HSV1-antibody responses in paired serum/CSF of 45 HSE patients (12 who developed postHSE-AE, 33 who did not; at onset and 1 month), and in serum of 12 periphHSV. Profiles included Ig classes/sublasses, Fc receptor binding, and Antibody-Dependent Cellular/Neutrophil Phagocytosis (ADCP/ADNP), Complement Deposition (ADCD) and NK-cells activation (ADNKA). Antibody features were compared across groups and compartments, and correlated with disease severity and development of postHSE-AE. Neuronal death was quantified in HSV1-infected cultures treated with IgG from HSE, periphHSV or healthy controls.
In HSE, HSV1-specific responses in CSF were low at onset, but significantly increased at 1 month, while serum responses remained elevated. LASSO/PLSDA analyses identified ADCD in serum and ADCP in CSF as features that differed most across compartments. Higher CSF-ADCP correlated with HSE severity. Compared to HSE, periphHSV patients showed higher serum ADNKA and FcgR3A binding despite similarly high IgG titers. Patients who developed PostHSE-AE exhibited higher titers, ADCD, ADNP and FcgR binding.
IgG from HSE patients caused increased neuronal death in-vitro compared to IgG from periphHSV or healthy controls.
Our results indicate that, during HSE, HSV1-responses are compartmentalized and characterized by phagocytosis-activating antibodies in CSF that correlate with HSE severity and predict PostHSE-AE. NK-activating antibodies in periphHSV may protect the brain from HSE. Antibodies from HSE cause increased neuronal death, which likely promotes the development of autoimmune encephalitis.
Recommended posters
ANTIBODY FC GLYCAN SIGNATURES TRACK WITH COMPARTMENTS, ETIOLOGY AND ONE-YEAR OUTCOMES IN ANTI-NMDA RECEPTOR ENCEPHALITIS
Giulia Cicalese, Laura Marmolejo, Alice Taddeucci, Claudia Papi, Chiara Milano, Esther Aguilar, Estibaliz Maudes, Ivana Duvnjak Orešković, Jerko Štambuk, Maja Pučić Baković, Gemma Olivé-Cirera, Mar Guasp, Eugenia Martinez-Hernandez, Thais Armangué, Josep Dalmau, Marianna Spatola
HSV-1 TRIGGERS ALZHEIMER-LIKE NEURODEGENERATIVE MARKERS IN GLIAL CELLS: A PROTECTIVE ROLE FOR LACTOFERRIN
María Martín Rico, Isabel Sastre, Blanca Salgado, Gema María Esteban, Beatriz Cubelos, María Jesús Bullido, Jesús Aldudo
IMMUNE-BRAIN CROSSTALK IN CASPR2 ENCEPHALITIS: THE ROLE OF BISPECIFIC IGG4
Diego Asensio-Wandosell Cabañas, Marina Mane Damas, Mario Losen, Pilar Martinez Martinez
CHARACTERIZATION OF BRAIN INNATE IMMUNE INFILTRATES, ANTIBODY DYNAMICS AND FUNCTIONALITIES IN A MOUSE MODEL OF ANTI-NMDAR ENCEPHALITIS
Laura Marmolejo Alcaide, Mariona Perez, Afnaan AlSabbry, Claudia Papi, Chiara Milano, Ana Beatriz Serafim, Jesus Planagumà, Esther Aguilar, Lidia Sabater, Estibaliz Maudes, Josep Dalmau, Marianna Spatola
NEUROIMMUNOLOGICAL BASIS OF ANTI-AMPAR ENCEPHALITIS
Justus Wilke, George Celis, Lauren Rodda, Eric Gouaux
PATIENT-DERIVED CSF FROM A CASE OF ANTI-DAGLA AUTOIMMUNE ENCEPHALITIS INDUCES SYNAPTIC DYSFUNCTION
Amelie Eichler, Fabian Gather, Tobias Hegelmaier, Noemi Calderon-Hampel, Ole Backhaus, Larissa Klukas, Emelie Janke, Tim Wüstefeld, Alexander Duscha, Aiden Haghikia, Maximilian Lenz